Five9, Inc. <FIVN.O>: Jefferies Raises Target Price to $28 From $21
FIVN•Related News
Csquare Inc <CSQR.N>: JP Morgan initiates coverage with neutral rating; target price $24
CSQR•
Silexion Therapeutics publishes corporate deck spotlighting SIL204 siRNA program targeting KRAS-driven cancers
SLXN•
Silence Therapeutics to discuss Phase 2 SANRECO trial topline results for divesiran in polycythemia vera
SLN•
KE Holdings files HKEX next-day return disclosing share repurchase for cancellation
BEKE•
Atlanticus Holdings Corp <ATLC.O>: Jefferies raises target price to $125 from $115
ATLC•